The future of health and wellness
begins with you.
Let's advance psychedelic science and mental health together.
Tens of thousands of people from around the world are accelerating research breakthroughs in mental health and psychedelic science - and you're invited.
Through the power of citizen-informed science, advocates and researchers are advancing policy, accelerating scientific discovery and conducting leading-edge psychedelic research.
Here's how it works
Participants share data.
Data is secured.
Researchers study the data.
Participants receive insights.
Researchers share their discoveries.
Help investigate the potential impact of ketamine-assisted psychotherapy (KAP) on psychological well-being in a real world setting. Join our study and impact its use as a treatment option for mental health conditions.
Meditation & Microdosing
This ground-breaking international study, co-led by Amanda Feilding, will explore the effects of regular microdosing on meditation practice and the evolution of meditation skills over time
Quantified Psychedelic Trips
Quantified Psychedelic Trips provides a platform to record a collection of experiences of people being under the recent influence of psychedelics.
This large-scale, clinician-led, observational study will primarily examine the impact of Ketamine Assisted Psychotherapy (KAP) on mental health outcomes in individuals with a range of mental health disorders.
We will assess data for relationships between current personality profiles and the history of substance use while comparing experienced substance users with naive ones. Additionally, we will also look at changes in personality over time and how these changes relate to reports on substance consumption.
Psychedelics and Wellness Synergy
The Psychedelics and Wellness Synergy (PAWS-30) study aims to explore the efficacy of an integrative, prescriptive, and trackable participant-managed wellness intervention program performed by individuals who have personally utilized a psychedelic substance within the previous two weeks prior to enrolling in the study.
Pain & Microdosing
Does psychedelic use contribute to reductions in chronic pain? This study will track pain symptoms and psychedelics use during a 3-month period using innovative mobile apps.